Trimtech Therapeutics raised £10.6M in a Seed round announced on June 23, 2026. biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases.
biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases.
Trimtech Therapeutics, based in Cambridge, United Kingdom, announced £10.6M in Seed financing on June 23, 2026.
Participants include BGF, Johnson & Johnson Innovation – JJDC.
CeQur is a medical device company that develops and manufactures wearable, injection-free insulin delivery solutions for people with diabetes.
Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
NewCore’s platform is designed to manage both human and AI-agent identities in a single system.